Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125993734 | 12599373 | 4 | F | 20160614 | 20160818 | 20160727 | 20160825 | EXP | FR-PFIZER INC-2016355779 | PFIZER | 62.00 | YR | F | Y | 0.00000 | 20160825 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125993734 | 12599373 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 100 MG, DAILY | Y | 21446 | 100 | MG | CAPSULE, HARD | ||||||
| 125993734 | 12599373 | 2 | SS | OFLOXACIN. | OFLOXACIN | 1 | Oral | 600 MG, DAILY | Y | 0 | 600 | MG | |||||||
| 125993734 | 12599373 | 3 | SS | OFLOXACIN. | OFLOXACIN | 1 | Oral | 400 MG, DAILY | Y | 0 | 400 | MG | |||||||
| 125993734 | 12599373 | 4 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 60 MG, DAILY | Y | 0 | 60 | MG | GASTRO-RESISTANT CAPSULE | ||||||
| 125993734 | 12599373 | 5 | SS | DUROGESIC | FENTANYL | 1 | Transdermal | 1 DF, EVERY 72 HOURS (75 MCG/HR (12.6 MG/31.5 CM2)) | Y | 0 | 1 | DF | TRANSDERMAL PATCH | ||||||
| 125993734 | 12599373 | 6 | C | RIMACTAN /00146901/ | RIFAMPIN | 1 | Oral | 900 MG, DAILY | 0 | 900 | MG | CAPSULE | |||||||
| 125993734 | 12599373 | 7 | C | OXYNORM | OXYCODONE HYDROCHLORIDE | 1 | Oral | 80 MG,MAXIMUM AS NEEDED | 0 | 80 | MG | CAPSULE | |||||||
| 125993734 | 12599373 | 8 | C | CORDARONE | AMIODARONE HYDROCHLORIDE | 1 | Oral | 200 MG, 1X/DAY | 0 | 200 | MG | TABLET | QD | ||||||
| 125993734 | 12599373 | 9 | C | LOXEN LP | NICARDIPINE | 1 | Oral | 100 MG, DAILY | 0 | 100 | MG | CAPSULE | |||||||
| 125993734 | 12599373 | 10 | C | BISOPROLOL FUMARATE. | BISOPROLOL FUMARATE | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | TABLET | |||||||
| 125993734 | 12599373 | 11 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | 75 UG, DAILY | 0 | 75 | UG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125993734 | 12599373 | 1 | Pain |
| 125993734 | 12599373 | 2 | Staphylococcal sepsis |
| 125993734 | 12599373 | 4 | Depression |
| 125993734 | 12599373 | 5 | Pain |
| 125993734 | 12599373 | 6 | Staphylococcal sepsis |
| 125993734 | 12599373 | 7 | Pain |
| 125993734 | 12599373 | 9 | Hypertension |
| 125993734 | 12599373 | 10 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125993734 | 12599373 | OT |
| 125993734 | 12599373 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125993734 | 12599373 | Confusional state | |
| 125993734 | 12599373 | Fall | |
| 125993734 | 12599373 | Glomerular filtration rate decreased | |
| 125993734 | 12599373 | Hallucination | |
| 125993734 | 12599373 | Hypothermia | |
| 125993734 | 12599373 | Seizure | |
| 125993734 | 12599373 | Staphylococcal bacteraemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125993734 | 12599373 | 1 | 20160617 | 20160619 | 0 | |
| 125993734 | 12599373 | 2 | 20160615 | 20160618 | 0 | |
| 125993734 | 12599373 | 3 | 20160619 | 20160619 | 0 | |
| 125993734 | 12599373 | 4 | 20160619 | 0 | ||
| 125993734 | 12599373 | 5 | 20160619 | 0 | ||
| 125993734 | 12599373 | 7 | 20160612 | 0 |